Anzeige
Mehr »
Login
Dienstag, 15.04.2025 Börsentäglich über 12.000 News von 690 internationalen Medien
Global Tactical tritt dem Critical Minerals Institute bei!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

GlobeNewswire (Europe)-Archiv vom 01.11.2024

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
01.11.2421Shares AG: Official Notice regarding the update on the name of 21Shares Ethereum Core ETP185The below was filed with SIX Exchange on 30 October 2024 in accordance with applicable regulations. Official Notice No.: 322516 Title: 21Shares AG (the "Company") - Official Notice regarding the update...
► Artikel lesen
01.11.24Titan N.V.: Titan N.V. reaches final settlement with SPS International, Inc. and SPS Commerce, Inc.220Titan N.V. ("Titan"), SPS International, Inc. ("SPS") and SPS Commerce, Inc. ("SPS Commerce") have entered into a settlement agreement regarding the claims of SPS and SPS Commerce against Titan as described...
► Artikel lesen
01.11.24LENSAR, Inc.: LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)148ORLANDO, Fla., Nov. 01, 2024 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or the "Company") today announced that a majority of the independent members of LENSAR's board of directors granted...
► Artikel lesen
01.11.24Prime Drink Group Corp.: Prime Drink Group Announces Closing of Triani Canada Acquisition156MONTREAL, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Prime Drink Group Corp. (CSE: PRME) ("Prime" or the "Company") announces it has closed its acquisition of all the issued and outstanding shares ("Triani...
► Artikel lesen
01.11.24South Bow Corporation: South Bow Recommends Shareholders Reject TRC Capital's Below-market "Mini-tender" Offer183CALGARY, Alberta, Nov. 01, 2024 (GLOBE NEWSWIRE) -- South Bow Corp. (TSX & NYSE: SOBO) has received an unsolicited "mini-tender" offer from TRC Capital Investment Corp. (TRC Capital) to purchase up...
► Artikel lesen
01.11.24ALX Oncology Announces Results from Phase 1b/2 Trial of Evorpacept in Combination with Zanidatamab will be Presented at the San Antonio Breast Cancer Symposium (SABCS) 2024175SOUTH SAN FRANCISCO, Calif., Nov. 01, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology" or "the Company") (Nasdaq: ALXO), a clinical-stage biotechnology company advancing therapies...
► Artikel lesen
01.11.24NewAmsterdam Pharma Company N.V.: NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)160NAARDEN, The Netherlands and MIAMI, Nov. 01, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or "NewAmsterdam" or the "Company"), a late-stage, clinical biopharmaceutical company...
► Artikel lesen
01.11.24Partners Value Investments L.P. Announces Changes to Internal Group Capital Structure121TORONTO, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Partners Value Investments L.P. (TSXV: PVF.UN, PVF.PR.U) (the "Partnership"), Partners Value Investments Inc. (TSXV: PVF.WT, PVF.PR.V) ("PVII") and Partners...
► Artikel lesen
01.11.24Lumine Group Inc. Announces Results for the Three and Nine Months Ended September 30, 2024188TORONTO, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Lumine Group Inc. ("Lumine Group" or "the Company") (TSXV:LMN) announces financial results for the three and nine months ended September 30, 2024. All amounts...
► Artikel lesen
01.11.24Lipella Pharmaceuticals Inc.: Lipella Pharmaceuticals Announces 1-for-8 Reverse Stock Split154PITTSBURGH, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (the "Company," "our" or "us"), a clinical-stage biotechnology company focused on developing innovative therapies...
► Artikel lesen
01.11.24Lilium N.V.: Lilium N.V. Receives Notice of Delisting from Nasdaq686MUNICH, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Lilium N.V. (Nasdaq: LILM) (the "Company" or "Lilium"), a leading electric aircraft manufacturer and pioneer in Regional Air Mobility (RAM), on Tuesday, October...
► Artikel lesen
01.11.24Taysha Gene Therapies, Inc.: Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)124DALLAS, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based...
► Artikel lesen
01.11.24ORIC Pharmaceuticals: ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)147SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Nov. 01, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address...
► Artikel lesen
01.11.24Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)254BOSTON, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on October 31, 2024...
► Artikel lesen
01.11.24Crown LNG Announces Execution of Final Agreements to Acquire Kakinada and Grangemouth LNG Import Terminal Assets196LONDON, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Crown LNG Holdings Limited (Nasdaq: CGBS) ("Crown" or "Crown LNG"), a leading provider of LNG liquefaction and regasification terminal technologies for harsh...
► Artikel lesen
01.11.24Nuwellis, Inc.: Nuwellis Announces Preliminary Results for Third Quarter of 2024255MINNEAPOLIS, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical device company dedicated to transforming the lives of patients suffering from fluid overload, today announced...
► Artikel lesen
01.11.24Parsons Corporation: Parsons Completes Acquisition of BCC Engineering195CHANTILLY, Va., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE:PSN) announced today that it has completed the previously announced acquisition of BCC Engineering, LLC (BCC), one of Florida's...
► Artikel lesen
01.11.24Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)166REDWOOD CITY, Calif., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (Nasdaq: BMEA) ("Biomea" or the "Company"), a clinical stage biopharmaceutical company focused on the discovery and development...
► Artikel lesen
01.11.24X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)155BOSTON, Nov. 01, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective...
► Artikel lesen
01.11.24Elcora Advanced Materials Corp.: Elcora Announces Revocation of Management Cease Trade Order271HALIFAX, Nova Scotia, Nov. 01, 2024 (GLOBE NEWSWIRE) -- ELCORA ADVANCED MATERIALS CORP. (TSX.V:ERA | Frankfurt:ELM | OTCQB - ECORF), (the "Company" or "Elcora"), announces that the Company's principal...
► Artikel lesen
Seite:  Weiter >>